表紙
市場調查報告書

同類幹細胞的全球市場:2020年∼2024年

Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 920025
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
同類幹細胞的全球市場:2020年∼2024年 Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年12月11日內容資訊: 英文 131 Pages
簡介

全球同類幹細胞市場上,新產品的認證,再生醫療領域的策略性聯盟增加,再生醫療領域的投資等成為成長促進因素,在預測期間內預計將以12%以上的年複合成長率擴大。但,嚴格法規,同類幹細胞療法的高成本,及幹細胞療法伴隨的嚴重併發症等要素,的可能妨礙在預測期間內同類幹細胞產業的成長。

本報告提供全球同類幹細胞市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2019年∼2024年)
  • 再生療法
  • 藥物研發及開發
  • 市場機會:各應用領域

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 幹細胞的認識高漲
  • 幹細胞療法的研究開發活動的增加
  • 特別藥的指定

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • 武田藥品工業

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40709

About this market

Technavio's allogeneic stem cells market analysis considers sales from regenerative therapy and drug discovery and development applications. Our study also finds the sales of allogeneic stem cells in Asia, Europe, North America, and ROW. In 2019, the regenerative therapy segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as functional restoration of tissues will play a significant role in the regenerative therapy segment to maintain its market position. Also, our global allogeneic stem cells market report looks at factors such as new product approvals, increasing strategic alliances in the field of regenerative medicines, and investments in the field of regenerative medicines. However, stringent regulations, high cost of allogeneic stem cell therapies, and serious complications associated with stem cell therapies may hamper the growth of the allogeneic stem cell industry over the forecast period.

Overview

New product approvals

The new product approvals and special drug designations are anticipated to boost the growth of the market. Based on the application, the allogeneic stem cells market has been segmented into regenerative therapy and drug discovery and development. Manufacturers are increasingly emphasizing innovations and improvisation in the development of regenerative therapies. Many of the regenerative therapeutic candidates have obtained approval for clinical trials in the US, Europe, and APAC due to the efficacy of allogeneic stem cell therapeutics. This is encouraging market players to launch new product lines to stimulate the overall product demand for stem or regenerative therapy using allogeneic stem cell therapeutics and provide better options for their customers. Thus, new product approvals will lead to the expansion of the global allogeneic stem cells market at a CAGR of over 12% during the forecast period.

Special drug designations

Research in the field of stem cell focuses mainly on developing new treatments for deadly diseases, which have negligible treatment using traditional treatment options. Thus, therapeutic candidates, which are currently under development, have been awarded special drug designations by regulatory bodies considering their proven efficacy. Many drugs received designations such as the breakthrough drug designation and the orphan drug designation from regulatory bodies such as the US FDA and the EMA. Drug designations enhance the research and enable drugs to reach the market and provides strong incentives, which in turn, encourages vendors to expedite R&D on novel therapies such as allogeneic stem cell therapy. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global allogeneic stem cells market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global allogeneic stem cells market is highly concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading allogeneic stem cells manufacturers, that include Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.

Also, the allogeneic stem cells market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Regenerative therapy - Market size and forecast 2019-2024
  • Drug discovery and development - Market size and forecast 2019-2024
  • Market opportunity by application

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rising awareness of stem cells
  • Increasing R&D activities in stem cell therapy
  • Special drug designations

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Biosolution Co. Ltd.
  • Cynata Therapeutics Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Lineage Cell Therapeutics Inc.
  • MEDIPOST Co. Ltd.
  • MiMedx Group Inc.
  • Osiris Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Application - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by application
  • Exhibit 20: Regenerative therapy - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Regenerative therapy - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Drug discovery and development - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Drug discovery and development - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by application
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: New product approvals
  • Exhibit 39: Complications associated with stem cell therapies
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Drug designations
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Biosolution Co. Ltd. - Vendor overview
  • Exhibit 48: Biosolution Co. Ltd. - Business segments
  • Exhibit 49: Biosolution Co. Ltd. - Key offerings
  • Exhibit 50: Cynata Therapeutics Ltd. - Vendor overview
  • Exhibit 51: Cynata Therapeutics Ltd. - Business segments
  • Exhibit 52: Cynata Therapeutics Ltd. - Organizational developments
  • Exhibit 53: Cynata Therapeutics Ltd. - Key offerings
  • Exhibit 54: JCR Pharmaceuticals Co. Ltd. - Vendor overview
  • Exhibit 55: JCR Pharmaceuticals Co. Ltd. - Business segments
  • Exhibit 56: JCR Pharmaceuticals Co. Ltd. - Segment focus
  • Exhibit 57: JCR Pharmaceuticals Co. Ltd. - Key offerings
  • Exhibit 58: Lineage Cell Therapeutics Inc. - Vendor overview
  • Exhibit 59: Lineage Cell Therapeutics Inc. - Business segments
  • Exhibit 60: Lineage Cell Therapeutics Inc. - Geographic focus
  • Exhibit 61: Lineage Cell Therapeutics Inc. - Key offerings
  • Exhibit 62: MEDIPOST Co. Ltd. - Vendor overview
  • Exhibit 63: MEDIPOST Co. Ltd. - Business segments
  • Exhibit 64: MEDIPOST Co. Ltd. - Organizational developments
  • Exhibit 65: MEDIPOST Co. Ltd. - Key offerings
  • Exhibit 66: MiMedx Group Inc. - Vendor overview
  • Exhibit 67: MiMedx Group Inc. - Business segments
  • Exhibit 68: MiMedx Group Inc. - Organizational developments
  • Exhibit 69: MiMedx Group Inc. - Key offerings
  • Exhibit 70: Osiris Therapeutics Inc. - Vendor overview
  • Exhibit 71: Osiris Therapeutics Inc. - Business segments
  • Exhibit 72: Osiris Therapeutics Inc. - Organizational developments
  • Exhibit 73: Osiris Therapeutics Inc. - Key offerings
  • Exhibit 74: Stempeutics Research Pvt. Ltd. - Vendor overview
  • Exhibit 75: Stempeutics Research Pvt. Ltd. - Product segments
  • Exhibit 76: Stempeutics Research Pvt. Ltd. - Key offerings
  • Exhibit 77: Takeda Pharmaceutical Co. Ltd. - Vendor overview
  • Exhibit 78: Takeda Pharmaceutical Co. Ltd. - Business segments
  • Exhibit 79: Takeda Pharmaceutical Co. Ltd. - Organizational developments
  • Exhibit 80: Takeda Pharmaceutical Co. Ltd. - Geographic focus
  • Exhibit 81: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibit 82: Validation techniques employed for market sizing
  • Exhibit 83: Definition of market positioning of vendors